However, SARS-CoV-2–infected lung cancer cell lines A549 and Calu-3a revealed down-regulation of SREBP2 (Gomez Marti et al, 2021), indicating cell-dependent and differential outcome of SARS-CoV-2 infection on cholesterol homeostasis and SREBP2 activity. This evidence concerns the gene SREBF2 and lung carcinoma.